Press Releases :: IceCure Medical Ltd. (ICCM)

Skip to main content Skip to section navigation Skip to footer

Jul 17, 2023 8:00 am EDT

IceCure Medical Expands Distribution of ProSense® into Portugal Through Agreement with Medicinália Cormédica: Upfront Systems & Probes Sales

Jun 13, 2023 8:00 am EDT

IceCure Medical to Review Recent Progress at Maxim Group's Virtual Healthcare Conference

May 31, 2023 8:00 am EDT

IceCure's ProSense Installation in India is the First to Offer Cryoablation for the Treatment of Breast Cancer in the Country

May 22, 2023 8:00 am EDT

IceCure Medical Reports First Quarter 2023 Financial & Operational Results

May 15, 2023 8:25 am EDT

IceCure to Report First Quarter 2023 Financial & Operational Results on May 22, 2023

May 15, 2023 8:00 am EDT

IceCure to Report First Quarter 2023 Financial & Operational Results on

May 01, 2023 8:00 am EDT

Cryoablation Takes Center Stage at American Society of Breast Surgeons' 24th Annual Meeting

Apr 24, 2023 8:00 am EDT

IceCure Medical to Provide Educational Support in a First-of-its-Kind Cryotherapy Course at the American Society of Breast Surgeons' 24th Annual Meeting

Apr 20, 2023 8:00 am EDT

IceCure's ProSense System Used in Endometriosis Cryoablation Study That Demonstrated Efficacy Rate of 92.8% to Avoid Secondary Surgery

Apr 19, 2023 8:00 am EDT

IceCure Medical Ordinary Shares to Trade Exclusively on Nasdaq: Company to Voluntarily Delist Shares from Trading on the Tel Aviv Stock Exchange

Select a page:

rss_feed News RSS

IceCure Medical HQ: 7 Ha’Eshel St., PO Box 3163, Caesarea, 3079504, Israel

© 2023 All Rights Reserved IceCure Medical

Branding by

Terms of Use | Privacy | Last Updated: April 9, 2023